Dr. James C. Stevens, MD

Dr. Stevens practices at Ascension St Vincent Hospital- Indianapolis in Indianapolis, Indiana.

Dr. Stevens' NPI, 1437156239, was assigned on July 7, 2005. Dr. Stevens graduated from Indiana University School of Medicine in 1983. Dr. Stevens holds Indiana license 01033527A.

Dr. Stevens' primary practice is Ascension St Vincent Hospital- Indianapolis, at 2001 W 86th St, Indianapolis, IN 46260 in Marion County. The practice phone is (317) 338-2172.

Dr. Stevens' primary practice is Ascension St Vincent Hospital- Indianapolis in Indianapolis, Indiana. Dr. Stevens is also affiliated with IU Health Methodist Hospital. The medical group on file is IU Health Medical Group. Dmand AI also links Dr. Stevens to 4 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Stevens practices, 7 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Stevens' primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Stevens is licensed in Indiana.

CMS data shows 73,697 Medicare services from Dr. Stevens across 19 procedure codes in 2024, for 452 Medicare patients. Medicare paid $135,351 for them.

CMS counts 452 Medicare patients who saw Dr. Stevens in 2024. The largest group is 65 to 74, with 208 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.41, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Stevens' median patient age at 65, with 54% women.

In 2024, Dr. Stevens wrote 3,016 Medicare Part D claims for 478 patients. 87% of them were for generic drugs. CMS names the drug for 2,733 of them, across 65 drugs with 11 or more claims each, at $1,649,621 in total drug cost. In 2023, CMS named 2,758 claims across 61 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 50 out of 100 for Dr. Stevens for performance year 2024, reported as part of a group. Dr. Stevens accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Stevens as offering telehealth.

Dmand AI links 16 papers to Dr. Stevens, published from 2010 to 2023. 2013 was the busiest year, with 2. The most frequent topics are Prions, Diagnosis, Differential and Muscle Spasticity. Dr. Stevens has published most often in J Neurol Neurosurg Psychiatry. Dr. Stevens' most frequent co-authors are Piero G. Antuono, MD, Antonio Culebras, MD and Pierre B. Fayad, MD.

Dmand AI links Dr. Stevens to 5 clinical trials, 2 of them phase 3 studies. Conditions studied include Alzheimer Disease, Tauopathies and Cataplexy. Eli Lilly and Company sponsors the most, 2. Open Payments lists research payments to Dr. Stevens that name 1 trial.

CMS Open Payments shows 359 general payments to Dr. Stevens from 32 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 71% of the total. Sanofi and Genzyme US Companies paid the most, $18,726. It also lists 4 research payments totaling $28,157 from 2016 to 2018, naming 1 clinical trial.

Dr. Stevens graduated from Indiana University School of Medicine in 1983.